Asahi Glass plans to acquire Denmark’s CMC Biologics S/A, a biopharmaceutical manufacturer

The acquisition amount is about 60 billion Yen and still needs approval by antitrust law authorities

Nikkei Biotech news release, December 22, 2016

Asahi Glass plans to acquire Denmark’s CMC Biologics S/A, a biopharmaceutical manufacturer
Scroll to top